Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Targeted Rhesus immunoglobulin for RhD negative women undergoing an induced abortion: a clinical pilot study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Maternal short-term complications after planned cesarean delivery without medical indication: A registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Outcomes of monoamniotic twin pregnancies managed primarily in outpatient care-A Danish multicenter study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Perioperative cardiovascular complications following urogynecological operations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mortality and morbidity of major congenital heart disease related to general prenatal screening for malformations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Blood group genotyping of blood donors: validation of a highly accurate routine method

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tracing the origin of adult intestinal stem cells

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. Characterization of Human Adrenal Steroidogenesis during Fetal Development

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Introduction: The aim of this clinical pilot study was to examine the accuracy of noninvasive fetal RHD genotyping in early pregnancy (8 +0  to 11 +6  weeks) and to clarify whether targeted administration of Rhesus immunoglobulin (RhIg) is possible for women undergoing an induced abortion such that unnecessary injections can be avoided. The study examines the correlation between gestational age and the amount of cell-free fetal DNA in maternal plasma, the fetal fraction of DNA and whether transportation time or body mass index affects these parameters. Material and methods: Fifty-two RhD-negative women undergoing a surgically induced abortion were included. A maternal blood sample was collected prior to the abortion and a tissue sample was collected from the placental part of the abortion material after the intervention. Fetal RhD type was determined by PCR analysis of cell-free fetal DNA extracted from maternal plasma and on DNA from the tissue sample, with the latter providing a reference standard. Copies of RHD/mL were determined on RHD-positive samples and the fetal fraction of DNA was calculated. Results: We demonstrated complete concordance between results from plasma and tissue, with 31 RhD-positive and 21 RhD-negative samples, corresponding to 40% being RhD-negative, specificity 100% [95% confidence interval (CI) 88.8-100] and sensitivity 100% (95% CI 83.9-100). We found no significant correlation between gestational age and the amount or the fraction of cell-free fetal DNA in maternal plasma, nor did we find that transportation time or BMI significantly affected these factors in this setup. Conclusions: Fetal RHD genotyping can be accurately performed from the 8th week of gestation and unnecessary injections of RhIg can be avoided for women undergoing an induced abortion. A larger study is needed to determine a more accurate sensitivity for the analysis early in pregnancy.

OriginalsprogEngelsk
TidsskriftActa Obstetricia et Gynecologica Scandinavica
Vol/bind98
Udgave nummer9
Sider (fra-til)1164-1171
Antal sider8
ISSN0001-6349
DOI
StatusUdgivet - sep. 2019

ID: 56813113